APO Research, Inc.

APO RESEARCH · REPORT

Carbapenem

Selected research

Market Analysis & Forecast

Global Carbapenem Market Analysis and Forecast 2026-2032

Market perspective

The global Carbapenem market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Carbapenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Carbapenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Carbapenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Carbapenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Carbapenem include Sun Pharmaceutical Industries, Pfizer, Haibin Pharmaceutical, United Lab, Savior Lifetec, Kopran and HISUN Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Carbapenem, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Carbapenem, also provides the sales of main regions and countries. Of the upcoming market potential for Carbapenem, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Carbapenem sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Carbapenem market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Carbapenem sales, projected growth trends, production technology, application and end-user industry.

Carbapenem Segment by Company

Sun Pharmaceutical Industries

Pfizer

Haibin Pharmaceutical

United Lab

Savior Lifetec

Kopran

HISUN Pharmaceutical

Carbapenem Segment by Type

Doripenem

Meropenem

Panipenem

Imipenem

Others

Carbapenem Segment by Application

Hosptials

Clinics

Others

Carbapenem Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carbapenem market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carbapenem and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carbapenem.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Carbapenem in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Carbapenem manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Carbapenem sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Carbapenem Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Doripenem Major Manufacturers Table 3. Meropenem Major Manufacturers Table 4. Panipenem Major Manufacturers Table 5. Imipenem Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Carbapenem Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hosptials Major Manufacturers Table 9. Clinics Major Manufacturers Table 10. Others Major Manufacturers Table 11. Carbapenem Industry Trends Table 12. Carbapenem Industry Drivers Table 13. Carbapenem Industry Opportunities and Challenges Table 14. Carbapenem Industry Restraints Table 15. Global Carbapenem Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Carbapenem Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Carbapenem Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Carbapenem Revenue Market Share by Region (2021-2026) Table 19. Global Carbapenem Revenue Market Share by Region (2027-2032) Table 20. Global Carbapenem Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 21. Global Carbapenem Sales by Region (2021-2026) & (tons) Table 22. Global Carbapenem Sales by Region (2027-2032) & (tons) Table 23. Global Carbapenem Sales Market Share by Region (2021-2026) Table 24. Global Carbapenem Sales Market Share by Region (2027-2032) Table 25. Global Carbapenem Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Carbapenem Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Carbapenem Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Carbapenem Sales Market Share by Manufacturers (2021-2026) Table 29. Global Carbapenem Sales Price (US$/kg) of Manufacturers (2021-2026) Table 30. Global Carbapenem Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Carbapenem Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Carbapenem Manufacturers, Product Type & Application Table 33. Global Carbapenem Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Carbapenem by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Carbapenem Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Carbapenem Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Carbapenem Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Carbapenem Revenue Market Share by Type (2021-2026) Table 40. Global Carbapenem Revenue Market Share by Type (2027-2032) Table 41. Global Carbapenem Sales by Type 2021 VS 2025 VS 2032 (tons) Table 42. Global Carbapenem Sales by Type (2021-2026) & (tons) Table 43. Global Carbapenem Sales by Type (2027-2032) & (tons) Table 44. Global Carbapenem Sales Market Share by Type (2021-2026) Table 45. Global Carbapenem Sales Market Share by Type (2027-2032) Table 46. Global Carbapenem Price by Type (2021-2026) & (US$/kg) Table 47. Global Carbapenem Price by Type (2027-2032) & (US$/kg) Table 48. Global Carbapenem Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Carbapenem Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Carbapenem Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Carbapenem Revenue Market Share by Application (2021-2026) Table 52. Global Carbapenem Revenue Market Share by Application (2027-2032) Table 53. Global Carbapenem Sales by Application 2021 VS 2025 VS 2032 (tons) Table 54. Global Carbapenem Sales by Application (2021-2026) & (tons) Table 55. Global Carbapenem Sales by Application (2027-2032) & (tons) Table 56. Global Carbapenem Sales Market Share by Application (2021-2026) Table 57. Global Carbapenem Sales Market Share by Application (2027-2032) Table 58. Global Carbapenem Price by Application (2021-2026) & (US$/kg) Table 59. Global Carbapenem Price by Application (2027-2032) & (US$/kg) Table 60. Sun Pharmaceutical Industries Company Information Table 61. Sun Pharmaceutical Industries Business Overview Table 62. Sun Pharmaceutical Industries Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 63. Sun Pharmaceutical Industries Carbapenem Product Portfolio Table 64. Sun Pharmaceutical Industries Recent Development Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 68. Pfizer Carbapenem Product Portfolio Table 69. Pfizer Recent Development Table 70. Haibin Pharmaceutical Company Information Table 71. Haibin Pharmaceutical Business Overview Table 72. Haibin Pharmaceutical Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 73. Haibin Pharmaceutical Carbapenem Product Portfolio Table 74. Haibin Pharmaceutical Recent Development Table 75. United Lab Company Information Table 76. United Lab Business Overview Table 77. United Lab Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 78. United Lab Carbapenem Product Portfolio Table 79. United Lab Recent Development Table 80. Savior Lifetec Company Information Table 81. Savior Lifetec Business Overview Table 82. Savior Lifetec Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 83. Savior Lifetec Carbapenem Product Portfolio Table 84. Savior Lifetec Recent Development Table 85. Kopran Company Information Table 86. Kopran Business Overview Table 87. Kopran Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 88. Kopran Carbapenem Product Portfolio Table 89. Kopran Recent Development Table 90. HISUN Pharmaceutical Company Information Table 91. HISUN Pharmaceutical Business Overview Table 92. HISUN Pharmaceutical Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 93. HISUN Pharmaceutical Carbapenem Product Portfolio Table 94. HISUN Pharmaceutical Recent Development Table 95. North America Carbapenem Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Carbapenem Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Carbapenem Sales by Type (2021-2026) & (tons) Table 98. North America Carbapenem Sales by Type (2027-2032) & (tons) Table 99. North America Carbapenem Sales Price by Type (2021-2026) & (US$/kg) Table 100. North America Carbapenem Sales Price by Type (2027-2032) & (US$/kg) Table 101. North America Carbapenem Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Carbapenem Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Carbapenem Sales by Application (2021-2026) & (tons) Table 104. North America Carbapenem Sales by Application (2027-2032) & (tons) Table 105. North America Carbapenem Sales Price by Application (2021-2026) & (US$/kg) Table 106. North America Carbapenem Sales Price by Application (2027-2032) & (US$/kg) Table 107. North America Carbapenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America Carbapenem Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. North America Carbapenem Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. North America Carbapenem Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 111. North America Carbapenem Sales by Country (2021-2026) & (tons) Table 112. North America Carbapenem Sales by Country (2027-2032) & (tons) Table 113. North America Carbapenem Sales Price by Country (2021-2026) & (US$/kg) Table 114. North America Carbapenem Sales Price by Country (2027-2032) & (US$/kg) Table 115. United States Carbapenem Revenue (2021-2032) & (US$ Million) Table 116. Canada Carbapenem Revenue (2021-2032) & (US$ Million) Table 117. Mexico Carbapenem Revenue (2021-2032) & (US$ Million) Table 118. Europe Carbapenem Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Carbapenem Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Carbapenem Sales by Type (2021-2026) & (tons) Table 121. Europe Carbapenem Sales by Type (2027-2032) & (tons) Table 122. Europe Carbapenem Sales Price by Type (2021-2026) & (US$/kg) Table 123. Europe Carbapenem Sales Price by Type (2027-2032) & (US$/kg) Table 124. Europe Carbapenem Revenue by Application (2021-2026) & (US$ Million) Table 125. Europe Carbapenem Revenue by Application (2027-2032) & (US$ Million) Table 126. Europe Carbapenem Sales by Application (2021-2026) & (tons) Table 127. Europe Carbapenem Sales by Application (2027-2032) & (tons) Table 128. Europe Carbapenem Sales Price by Application (2021-2026) & (US$/kg) Table 129. Europe Carbapenem Sales Price by Application (2027-2032) & (US$/kg) Table 130. Europe Carbapenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe Carbapenem Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. Europe Carbapenem Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. Europe Carbapenem Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 134. Europe Carbapenem Sales by Country (2021-2026) & (tons) Table 135. Europe Carbapenem Sales by Country (2027-2032) & (tons) Table 136. Europe Carbapenem Sales Price by Country (2021-2026) & (US$/kg) Table 137. Europe Carbapenem Sales Price by Country (2027-2032) & (US$/kg) Table 138. Germany Carbapenem Revenue (2021-2032) & (US$ Million) Table 139. France Carbapenem Revenue (2021-2032) & (US$ Million) Table 140. U.K. Carbapenem Revenue (2021-2032) & (US$ Million) Table 141. Italy Carbapenem Revenue (2021-2032) & (US$ Million) Table 142. Russia Carbapenem Revenue (2021-2032) & (US$ Million) Table 143. Spain Carbapenem Revenue (2021-2032) & (US$ Million) Table 144. Netherlands Carbapenem Revenue (2021-2032) & (US$ Million) Table 145. Switzerland Carbapenem Revenue (2021-2032) & (US$ Million) Table 146. Sweden Carbapenem Revenue (2021-2032) & (US$ Million) Table 147. Poland Carbapenem Revenue (2021-2032) & (US$ Million) Table 148. China Carbapenem Revenue by Type (2021-2026) & (US$ Million) Table 149. China Carbapenem Revenue by Type (2027-2032) & (US$ Million) Table 150. China Carbapenem Sales by Type (2021-2026) & (tons) Table 151. China Carbapenem Sales by Type (2027-2032) & (tons) Table 152. China Carbapenem Sales Price by Type (2021-2026) & (US$/kg) Table 153. China Carbapenem Sales Price by Type (2027-2032) & (US$/kg) Table 154. China Carbapenem Revenue by Application (2021-2026) & (US$ Million) Table 155. China Carbapenem Revenue by Application (2027-2032) & (US$ Million) Table 156. China Carbapenem Sales by Application (2021-2026) & (tons) Table 157. China Carbapenem Sales by Application (2027-2032) & (tons) Table 158. China Carbapenem Sales Price by Application (2021-2026) & (US$/kg) Table 159. China Carbapenem Sales Price by Application (2027-2032) & (US$/kg) Table 160. Asia Carbapenem Revenue by Type (2021-2026) & (US$ Million) Table 161. Asia Carbapenem Revenue by Type (2027-2032) & (US$ Million) Table 162. Asia Carbapenem Sales by Type (2021-2026) & (tons) Table 163. Asia Carbapenem Sales by Type (2027-2032) & (tons) Table 164. Asia Carbapenem Sales Price by Type (2021-2026) & (US$/kg) Table 165. Asia Carbapenem Sales Price by Type (2027-2032) & (US$/kg) Table 166. Asia Carbapenem Revenue by Application (2021-2026) & (US$ Million) Table 167. Asia Carbapenem Revenue by Application (2027-2032) & (US$ Million) Table 168. Asia Carbapenem Sales by Application (2021-2026) & (tons) Table 169. Asia Carbapenem Sales by Application (2027-2032) & (tons) Table 170. Asia Carbapenem Sales Price by Application (2021-2026) & (US$/kg) Table 171. Asia Carbapenem Sales Price by Application (2027-2032) & (US$/kg) Table 172. Asia Carbapenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Asia Carbapenem Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Asia Carbapenem Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Asia Carbapenem Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 176. Asia Carbapenem Sales by Country (2021-2026) & (tons) Table 177. Asia Carbapenem Sales by Country (2027-2032) & (tons) Table 178. Asia Carbapenem Sales Price by Country (2021-2026) & (US$/kg) Table 179. Asia Carbapenem Sales Price by Country (2027-2032) & (US$/kg) Table 180. Japan Carbapenem Revenue (2021-2032) & (US$ Million) Table 181. South Korea Carbapenem Revenue (2021-2032) & (US$ Million) Table 182. India Carbapenem Revenue (2021-2032) & (US$ Million) Table 183. Australia Carbapenem Revenue (2021-2032) & (US$ Million) Table 184. Taiwan Carbapenem Revenue (2021-2032) & (US$ Million) Table 185. Southeast Asia Carbapenem Revenue (2021-2032) & (US$ Million) Table 186. SAMEA Carbapenem Revenue by Type (2021-2026) & (US$ Million) Table 187. SAMEA Carbapenem Revenue by Type (2027-2032) & (US$ Million) Table 188. SAMEA Carbapenem Sales by Type (2021-2026) & (tons) Table 189. SAMEA Carbapenem Sales by Type (2027-2032) & (tons) Table 190. SAMEA Carbapenem Sales Price by Type (2021-2026) & (US$/kg) Table 191. SAMEA Carbapenem Sales Price by Type (2027-2032) & (US$/kg) Table 192. SAMEA Carbapenem Revenue by Application (2021-2026) & (US$ Million) Table 193. SAMEA Carbapenem Revenue by Application (2027-2032) & (US$ Million) Table 194. SAMEA Carbapenem Sales by Application (2021-2026) & (tons) Table 195. SAMEA Carbapenem Sales by Application (2027-2032) & (tons) Table 196. SAMEA Carbapenem Sales Price by Application (2021-2026) & (US$/kg) Table 197. SAMEA Carbapenem Sales Price by Application (2027-2032) & (US$/kg) Table 198. SAMEA Carbapenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. SAMEA Carbapenem Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. SAMEA Carbapenem Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. SAMEA Carbapenem Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 202. SAMEA Carbapenem Sales by Country (2021-2026) & (tons) Table 203. SAMEA Carbapenem Sales by Country (2027-2032) & (tons) Table 204. SAMEA Carbapenem Sales Price by Country (2021-2026) & (US$/kg) Table 205. SAMEA Carbapenem Sales Price by Country (2027-2032) & (US$/kg) Table 206. Brazil Carbapenem Revenue (2021-2032) & (US$ Million) Table 207. Argentina Carbapenem Revenue (2021-2032) & (US$ Million) Table 208. Chile Carbapenem Revenue (2021-2032) & (US$ Million) Table 209. Colombia Carbapenem Revenue (2021-2032) & (US$ Million) Table 210. Peru Carbapenem Revenue (2021-2032) & (US$ Million) Table 211. Saudi Arabia Carbapenem Revenue (2021-2032) & (US$ Million) Table 212. Israel Carbapenem Revenue (2021-2032) & (US$ Million) Table 213. UAE Carbapenem Revenue (2021-2032) & (US$ Million) Table 214. Turkey Carbapenem Revenue (2021-2032) & (US$ Million) Table 215. Iran Carbapenem Revenue (2021-2032) & (US$ Million) Table 216. Egypt Carbapenem Revenue (2021-2032) & (US$ Million) Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. Carbapenem Distributors List Table 220. Carbapenem Customers List Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. Carbapenem Image Figure 2. Global Carbapenem Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carbapenem Market Size Share 2021 VS 2025 VS 2032 Figure 4. Doripenem Image Figure 5. Meropenem Image Figure 6. Panipenem Image Figure 7. Imipenem Image Figure 8. Others Image Figure 9. Global Carbapenem Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Carbapenem Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hosptials Image Figure 12. Clinics Image Figure 13. Others Image Figure 14. Global Carbapenem Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Carbapenem Revenue (2021-2032) & (US$ Million) Figure 16. Global Carbapenem Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Carbapenem Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Carbapenem Revenue Market Share by Region (2021-2032) Figure 19. Global Carbapenem Sales (2021-2032) & (tons) Figure 20. Global Carbapenem Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 21. Global Carbapenem Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Carbapenem Sales YoY (2021-2032) & (tons) Figure 23. Europe Carbapenem Sales YoY (2021-2032) & (tons) Figure 24. China Carbapenem Sales YoY (2021-2032) & (tons) Figure 25. Asia (Excluding China) Carbapenem Sales YoY (2021-2032) & (tons) Figure 26. South America, Middle East and Africa Carbapenem Sales YoY (2021-2032) & (tons) Figure 27. Global Carbapenem Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Carbapenem Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Carbapenem Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Carbapenem Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Carbapenem Revenue Market Share by Type (2021-2032) Figure 33. Global Carbapenem Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 34. Global Carbapenem Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Carbapenem Sales Market Share by Type (2021-2032) Figure 36. Global Carbapenem Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Carbapenem Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Carbapenem Revenue Market Share by Application (2021-2032) Figure 39. Global Carbapenem Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 40. Global Carbapenem Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Carbapenem Sales Market Share by Application (2021-2032) Figure 42. North America Carbapenem Revenue Share by Type (2021-2032) Figure 43. North America Carbapenem Sales Share by Type (2021-2032) Figure 44. North America Carbapenem Revenue Share by Application (2021-2032) Figure 45. North America Carbapenem Sales Share by Application (2021-2032) Figure 46. North America Carbapenem Revenue Share by Country (2021-2032) Figure 47. North America Carbapenem Sales Share by Country (2021-2032) Figure 48. Europe Carbapenem Revenue Share by Type (2021-2032) Figure 49. Europe Carbapenem Sales Share by Type (2021-2032) Figure 50. Europe Carbapenem Revenue Share by Application (2021-2032) Figure 51. Europe Carbapenem Sales Share by Application (2021-2032) Figure 52. Europe Carbapenem Revenue Share by Country (2021-2032) Figure 53. Europe Carbapenem Sales Share by Country (2021-2032) Figure 54. China Carbapenem Revenue Share by Type (2021-2032) Figure 55. China Carbapenem Sales Share by Type (2021-2032) Figure 56. China Carbapenem Revenue Share by Application (2021-2032) Figure 57. China Carbapenem Sales Share by Application (2021-2032) Figure 58. Asia Carbapenem Revenue Share by Type (2021-2032) Figure 59. Asia Carbapenem Sales Share by Type (2021-2032) Figure 60. Asia Carbapenem Revenue Share by Application (2021-2032) Figure 61. Asia Carbapenem Sales Share by Application (2021-2032) Figure 62. Asia Carbapenem Revenue Share by Country (2021-2032) Figure 63. Asia Carbapenem Sales Share by Country (2021-2032) Figure 64. SAMEA Carbapenem Revenue Share by Type (2021-2032) Figure 65. SAMEA Carbapenem Sales Share by Type (2021-2032) Figure 66. SAMEA Carbapenem Revenue Share by Application (2021-2032) Figure 67. SAMEA Carbapenem Sales Share by Application (2021-2032) Figure 68. SAMEA Carbapenem Revenue Share by Country (2021-2032) Figure 69. SAMEA Carbapenem Sales Share by Country (2021-2032) Figure 70. Carbapenem Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Carbapenem Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Doripenem
  • Meropenem
  • Panipenem
  • Imipenem
  • Others
Applications
  • Hosptials
  • Clinics
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Pfizer
  • Haibin Pharmaceutical
  • United Lab
  • Savior Lifetec
  • Kopran
  • HISUN Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Carbapenem Market by Type
  3. 1.2.1 Global Carbapenem Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Doripenem
  5. 1.2.3 Meropenem
  6. 1.2.4 Panipenem
  7. 1.2.5 Imipenem
  8. 1.2.6 Others
  9. 1.3 Carbapenem Market by Application
  10. 1.3.1 Global Carbapenem Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hosptials
  12. 1.3.3 Clinics
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Carbapenem Market Dynamics
  1. 2.1 Carbapenem Industry Trends
  2. 2.2 Carbapenem Industry Drivers
  3. 2.3 Carbapenem Industry Opportunities and Challenges
  4. 2.4 Carbapenem Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Carbapenem Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Carbapenem Revenue by Region
  3. 3.2.1 Global Carbapenem Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Carbapenem Revenue by Region (2021-2026)
  5. 3.2.3 Global Carbapenem Revenue by Region (2027-2032)
  6. 3.2.4 Global Carbapenem Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Carbapenem Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Carbapenem Sales by Region
  9. 3.4.1 Global Carbapenem Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Carbapenem Sales by Region (2021-2026)
  11. 3.4.3 Global Carbapenem Sales by Region (2027-2032)
  12. 3.4.4 Global Carbapenem Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Carbapenem Revenue by Manufacturers
  2. 4.1.1 Global Carbapenem Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Carbapenem Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Carbapenem Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Carbapenem Sales by Manufacturers
  6. 4.2.1 Global Carbapenem Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Carbapenem Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Carbapenem Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Carbapenem Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Carbapenem Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Carbapenem Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Carbapenem Manufacturers, Product Type & Application
  13. 4.7 Global Carbapenem Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Carbapenem Market CR5 and HHI
  16. 4.8.2 2025 Carbapenem Tier 1, Tier 2, and Tier 3
5 Carbapenem Market by Type
  1. 5.1 Global Carbapenem Revenue by Type
  2. 5.1.1 Global Carbapenem Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Carbapenem Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Carbapenem Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Carbapenem Sales by Type
  6. 5.2.1 Global Carbapenem Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Carbapenem Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Carbapenem Sales Market Share by Type (2021-2032)
  9. 5.3 Global Carbapenem Price by Type
6 Carbapenem Market by Application
  1. 6.1 Global Carbapenem Revenue by Application
  2. 6.1.1 Global Carbapenem Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Carbapenem Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Carbapenem Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Carbapenem Sales by Application
  6. 6.2.1 Global Carbapenem Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Carbapenem Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Carbapenem Sales Market Share by Application (2021-2032)
  9. 6.3 Global Carbapenem Price by Application
7 Company Profiles
  1. 7.1 Sun Pharmaceutical Industries
  2. 7.1.1 Sun Pharmaceutical Industries Company Information
  3. 7.1.2 Sun Pharmaceutical Industries Business Overview
  4. 7.1.3 Sun Pharmaceutical Industries Carbapenem Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sun Pharmaceutical Industries Carbapenem Product Portfolio
  6. 7.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Carbapenem Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Carbapenem Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 Haibin Pharmaceutical
  14. 7.3.1 Haibin Pharmaceutical Company Information
  15. 7.3.2 Haibin Pharmaceutical Business Overview
  16. 7.3.3 Haibin Pharmaceutical Carbapenem Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Haibin Pharmaceutical Carbapenem Product Portfolio
  18. 7.3.5 Haibin Pharmaceutical Recent Developments
  19. 7.4 United Lab
  20. 7.4.1 United Lab Company Information
  21. 7.4.2 United Lab Business Overview
  22. 7.4.3 United Lab Carbapenem Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 United Lab Carbapenem Product Portfolio
  24. 7.4.5 United Lab Recent Developments
  25. 7.5 Savior Lifetec
  26. 7.5.1 Savior Lifetec Company Information
  27. 7.5.2 Savior Lifetec Business Overview
  28. 7.5.3 Savior Lifetec Carbapenem Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Savior Lifetec Carbapenem Product Portfolio
  30. 7.5.5 Savior Lifetec Recent Developments
  31. 7.6 Kopran
  32. 7.6.1 Kopran Company Information
  33. 7.6.2 Kopran Business Overview
  34. 7.6.3 Kopran Carbapenem Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kopran Carbapenem Product Portfolio
  36. 7.6.5 Kopran Recent Developments
  37. 7.7 HISUN Pharmaceutical
  38. 7.7.1 HISUN Pharmaceutical Company Information
  39. 7.7.2 HISUN Pharmaceutical Business Overview
  40. 7.7.3 HISUN Pharmaceutical Carbapenem Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 HISUN Pharmaceutical Carbapenem Product Portfolio
  42. 7.7.5 HISUN Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Carbapenem Market Size by Type
  2. 8.1.1 North America Carbapenem Revenue by Type (2021-2032)
  3. 8.1.2 North America Carbapenem Sales by Type (2021-2032)
  4. 8.1.3 North America Carbapenem Price by Type (2021-2032)
  5. 8.2 North America Carbapenem Market Size by Application
  6. 8.2.1 North America Carbapenem Revenue by Application (2021-2032)
  7. 8.2.2 North America Carbapenem Sales by Application (2021-2032)
  8. 8.2.3 North America Carbapenem Price by Application (2021-2032)
  9. 8.3 North America Carbapenem Market Size by Country
  10. 8.3.1 North America Carbapenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Carbapenem Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Carbapenem Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Carbapenem Market Size by Type
  2. 9.1.1 Europe Carbapenem Revenue by Type (2021-2032)
  3. 9.1.2 Europe Carbapenem Sales by Type (2021-2032)
  4. 9.1.3 Europe Carbapenem Price by Type (2021-2032)
  5. 9.2 Europe Carbapenem Market Size by Application
  6. 9.2.1 Europe Carbapenem Revenue by Application (2021-2032)
  7. 9.2.2 Europe Carbapenem Sales by Application (2021-2032)
  8. 9.2.3 Europe Carbapenem Price by Application (2021-2032)
  9. 9.3 Europe Carbapenem Market Size by Country
  10. 9.3.1 Europe Carbapenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Carbapenem Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Carbapenem Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Carbapenem Market Size by Type
  2. 10.1.1 China Carbapenem Revenue by Type (2021-2032)
  3. 10.1.2 China Carbapenem Sales by Type (2021-2032)
  4. 10.1.3 China Carbapenem Price by Type (2021-2032)
  5. 10.2 China Carbapenem Market Size by Application
  6. 10.2.1 China Carbapenem Revenue by Application (2021-2032)
  7. 10.2.2 China Carbapenem Sales by Application (2021-2032)
  8. 10.2.3 China Carbapenem Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Carbapenem Market Size by Type
  2. 11.1.1 Asia Carbapenem Revenue by Type (2021-2032)
  3. 11.1.2 Asia Carbapenem Sales by Type (2021-2032)
  4. 11.1.3 Asia Carbapenem Price by Type (2021-2032)
  5. 11.2 Asia Carbapenem Market Size by Application
  6. 11.2.1 Asia Carbapenem Revenue by Application (2021-2032)
  7. 11.2.2 Asia Carbapenem Sales by Application (2021-2032)
  8. 11.2.3 Asia Carbapenem Price by Application (2021-2032)
  9. 11.3 Asia Carbapenem Market Size by Country
  10. 11.3.1 Asia Carbapenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Carbapenem Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Carbapenem Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Carbapenem Market Size by Type
  2. 12.1.1 SAMEA Carbapenem Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Carbapenem Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Carbapenem Price by Type (2021-2032)
  5. 12.2 SAMEA Carbapenem Market Size by Application
  6. 12.2.1 SAMEA Carbapenem Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Carbapenem Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Carbapenem Price by Application (2021-2032)
  9. 12.3 SAMEA Carbapenem Market Size by Country
  10. 12.3.1 SAMEA Carbapenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Carbapenem Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Carbapenem Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Carbapenem Value Chain Analysis
  2. 13.1.1 Carbapenem Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Carbapenem Production Mode & Process
  6. 13.2 Carbapenem Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Carbapenem Distributors
  9. 13.2.3 Carbapenem Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.